Dong-a St Co., Ltd.
Clinical trials sponsored by Dong-a St Co., Ltd., explained in plain language.
-
New diabetes pill DA-2811 aims to improve blood sugar control
Disease control Not yet recruitingThis study tests an experimental drug, DA-2811, in 288 adults with type 2 diabetes whose blood sugar is not well controlled despite taking two other diabetes medications. Participants will receive either DA-2811 or a placebo added to their current treatment. The main goal is to s…
Phase: PHASE2 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New diabetes drug DA-5218 aims to help when metformin Isn't enough
Disease control Not yet recruitingThis study tests an experimental drug called DA-5218 in 238 adults with type 2 diabetes whose blood sugar is not well controlled by metformin alone. Participants will receive either DA-5218 or an active comparator, and researchers will measure changes in HbA1c over time. The tria…
Phase: PHASE4 • Sponsor: Dong-A ST Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New hope for chronic stomach pain: DA-9701 put to the test
Symptom relief Not yet recruitingThis trial tests whether DA-9701, a drug for stomach discomfort, works better than a placebo or another active drug in people with functional dyspepsia—a condition causing persistent stomach pain and bloating without a clear cause. About 300 adults aged 19 to 75 with moderate to …
Phase: PHASE4 • Sponsor: Dong-A ST Co., Ltd. • Aim: Symptom relief
Last updated Jul 09, 2026 00:00 UTC
-
Healthy volunteers needed to test drug equivalence
Knowledge-focused Not yet recruitingThis study aims to see if two versions of a drug, DA-5230 and DA-5230-R, are absorbed and processed by the body in the same way. It involves 60 healthy adults aged 19 to 55 who will receive a single dose of each version on separate days. The results will help determine if the two…
Phase: PHASE1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC